Professional Documents
Culture Documents
CRITICAL CARE
in racemic ketamine (s-ketamine) as observed in vitro. Lower urinary tract symptoms, including cystitis have been described.
Hydronephrosis has been very rarely reported
CONCLUSIONS: This case has a very peculiar presentation given the findings of severe electrolyte abnormalities, upper-urinary
tract and liver involvement. We highlight the importance of identifying this pathology for early intervention and appropriate
management and prevent long term sequelae.
REFERENCE #1: Zhu W, Ding Z, Zhang Y, Shi J, Hashimoto K, Lu L. Risks Associated with Misuse of Ketamine as a Rapid-
Acting Antidepressant. Neurosci Bull. Dec 2016;32(6):557-564. doi:10.1007/s12264-016-0081-2
REFERENCE #2: Wang JW, Kivovich V, Gordon L. Ketamine Abuse Syndrome: Hepatobiliary and Urinary Pathology Among
Adolescents in Flushing, NY. Pediatr Emerg Care. Aug 2017;33(8):e24-e26. doi:10.1097/PEC.0000000000000502
REFERENCE #3: Xu J, Lei H. Ketamine-an update on its clinical uses and abuses. CNS Neurosci Ther. Dec 2014;20(12):1015-20.
doi:10.1111/cns.12363
DISCLOSURES: No relevant relationships by Christiana Atuaka, source¼Web Response
No relevant relationships by Claudia De Araujo Duarte, source¼Web Response
Speaker/Speaker's Bureau relationship with pfizer Please note: $1001 - $5000 by Yizhak Kupfer, source¼Admin input,
value¼Consulting fee
chestjournal.org 617A
No relevant relationships by Sanwal Mehta, source¼Web Response
No relevant relationships by Ratnam Santoshi, source¼Web Response
DOI: https://doi.org/10.1016/j.chest.2021.07.592
Copyright ª 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
CRITICAL CARE